BMY News and Press, Bristol-Myers Squibb Company From 06/18/24

Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has elected independent director Michael R. McMullen to the Board, effective July 1, 2024. Mr. McMullen will serve as a member of the Audit Committee of the Board of Directors. “We are pleased to welcome Mr....

2024-06-18 10:00:00 ET When it comes to investing in high-yield dividend stocks in the pharmaceutical space, two prominent names often come to mind: Pfizer (NYSE: PFE) and Bristol Myers Squibb (NYSE: BMY) . Both companies have a long history of paying dividends and offer...

2024-06-18 07:04:41 ET More on Bristol-Myers Squibb Company Bristol-Myers Squibb: Move Investing Time Horizon To 2025, At Least Bristol-Myers Squibb: Could This Be A Value Trap? (Technical Analysis) Bristol-Myers Squibb Company (BMY) Goldman Sachs 45th Annual Global ...

2024-06-17 15:37:41 ET Summary For dividend growth investing, is growth more important than valuation? 49 stocks are valued based on Historical and Future Fair Valuations as well as analyst estimates. 49 stocks are further evaluated based on past dividend growth and future pro...

2024-06-17 10:47:03 ET Amazon.com Inc. (AMZN) AMZN is trading DOWN for the last 4 days, and it at trading at $182.91 with volume of 7,635,862 and a one day change of $-0.75 (-0.41%). Amazon.com Inc. has a 52-week low of 118.35 and a 52-week high of $191.70. The business's 50-day mov...

2024-06-17 09:45:40 ET Palm Beach, FL – June 17, 2024 – According to a report from Mordor Intelligence the Acute Myeloid Leukemia Market size is estimated at USD 1.83 billion in 2024, and is expected to reach USD 2.97 billion by 2029, growing at a CAGR of 10.15% during the...

2024-06-15 17:57:00 ET The S&P 500 is up an incredible 25% over the past 12 months, but not every stock in the benchmark index has participated in the rally. A handful of terrific healthcare stocks have fallen more than 25% from the peaks they set less than a year ago. Shares of P...

2024-06-15 10:58:09 ET Summary As expected, AstraZeneca's price has increased in the past quarter, and by a notable 18.4%, following a robust Q1 2024 performance. Recent approvals in the US market, earlier attractive market multiples and a dividend increase also supported the stoc...

2024-06-14 15:55:36 ET More on Bristol-Myers Squibb Company , Gilead Sciences, etc. Bristol-Myers Squibb: Move Investing Time Horizon To 2025, At Least Gilead Sciences, Inc. (GILD) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) Bristol-Myers...

2024-06-13 17:28:51 ET More on Bristol-Myers Squibb Company Bristol-Myers Squibb: Move Investing Time Horizon To 2025, At Least Bristol-Myers Squibb: Could This Be A Value Trap? (Technical Analysis) Bristol-Myers Squibb Company (BMY) Goldman Sachs 45th Annual Global ...